Johnson & Johnson (SNSE:JNJ)

Chile flag Chile · Delayed Price · Currency is CLP · Price in USD
217.47
0.00 (0.00%)
At close: Feb 17, 2026
Market Cap508.41T +41.4%
Revenue (ttm)85.20T +6.0%
Net Income24.24T +90.6%
EPS9,976.64 +90.5%
Shares Outn/a
PE Ratio20.97
Forward PE20.88
Dividend4,865.72 (2,237.42%)
Ex-Dividend DateNov 25, 2025
Volumen/a
Average Volumen/a
Openn/a
Previous Close217.47
Day's Rangen/a
52-Week Range143.62 - 217.47
Beta0.66
RSI100.00
Earnings DateJan 21, 2026

About Johnson & Johnson

Johnson & Johnson, together with its subsidiaries, engages in the research and development, manufacture, and sale of various products in the healthcare field worldwide. It operates in two segments, Innovative Medicine and MedTech. The Innovative Medicine segment offers products for various therapeutic areas, such as immunology, including rheumatoid arthritis, psoriatic arthritis, inflammatory bowel disease, and psoriasis; infectious diseases comprising HIV/AIDS; neuroscience, consisting of mood disorders, neurodegenerative disorders, and schizo... [Read more]

Industry Drug Manufacturers - General
Sector Healthcare
Founded 1886
Employees 138,100
Stock Exchange Santiago Stock Exchange
Ticker Symbol JNJ
Full Company Profile

Financial Performance

In 2025, Johnson & Johnson's revenue was $94.19 billion, an increase of 6.05% compared to the previous year's $88.82 billion. Earnings were $26.80 billion, an increase of 90.56%.

Financial numbers in USD Financial Statements